TreeHouse Foods (THS) Stock

TreeHouse concluded the acquisition of Harris Tea, strengthening its position in the private label tea market, expecting to boost profitability in 2025.

OAK BROOK, Ill. , Jan. 2, 2025 /PRNewswire/ -- TreeHouse Foods, Inc. (NYSE: THS) announced that it has completed its acquisition of Harris Tea for approximately $205 million.

THS Foods is struggling with weak consumer demand and operational disruptions, leading to dismal performance.

THS is facing challenges from weak consumer demand, operational disruptions and a voluntary product recall, leading to a lowered guidance.

CINCINNATI--(BUSINESS WIRE)--ProAmpac, a leader in flexible packaging and material science, has been recognized with TreeHouse Foods' prestigious 2024 Supplier Value Award for outstanding contributions to Environmental, Sustainability, and Governance (ESG). This award highlights ProAmpac's environmental stewardship, innovation, and service excellence across TreeHouse's operations and supply chain. “ProAmpac has been an exceptional partner in advancing our ESG initiatives,” said Jim O'Rourke, ch.

Reiterates 2024 Guidance OAK BROOK, Ill. , Dec. 2, 2024 /PRNewswire/ -- TreeHouse Foods, Inc. (NYSE: THS) ("the Company") today announced that it has signed a definitive agreement to acquire certain subsidiaries that operate the private brand tea business of Harris Freeman & Co, Inc. ("Harris Tea"), a leading private brand tea manufacturer in the U.S., for approximately $205 million, subject to customary purchase price adjustments.

THS is struggling with slowing consumer consumption and a shrinking private brand market, which is hindering its growth.

THS Q3 results show top-line pressures from the voluntary griddle recall and lower volume/mix, with significant margin improvements and y/y bottom-line growth.

TreeHouse Foods, Inc.'s shares dropped 16.7% due to weak Q3 results, impacted by a product recall and challenging economic conditions affecting consumer spending. Despite the setbacks, the recall's long-term impact is limited, and the stock remains undervalued compared to peers, justifying a 'buy' rating. Management revised revenue and cash flow guidance downward, but remains optimistic about long-term growth targets and market share gains in private brands.